期刊检索 >>

关键字:

风湿病与关节炎

  • 固话:18611675548
  • 地址:北京市朝阳区北四环东路115号院6号楼109室
  • 邮编:100101
  • Email:fsbygjy@163.com
  • 手机:18611675548
  • QQ号:2673938532
  • http://www.fsbygjy.com

您现在的位置:首页-电子期刊-电子期刊

玻璃酸钠联合复方倍他米松治疗膝骨关节炎44例临床观察

来源:http://www.fsbygjy.com 日期:2018/9/25点击量:914

来源:风湿病与关节炎,2018,78:24-26.

 

玻璃酸钠联合复方倍他米松治疗膝骨关节炎44例临床观察

(临床研究

 

杜立群

 

  【摘 要】目的:观察玻璃酸钠联合复方倍他米松治疗膝骨关节炎的临床疗效。方法:88例膝骨关节炎患者随机分为治疗组和对照组,每组44例。对照组给予玻璃酸钠关节腔内注射,治疗组在对照组治疗基础上加用复方倍他米松关节腔内注射。观察2组临床疗效,以及治疗前后视觉模拟评分法(VAS)评分、美国特种外科医院膝关节评分(HSS评分),治疗过程中药物不良反应情况。结果:治疗组显效14例,有效26例,无效4例,总有效率为90.91%;对照组显效10例,有效20例,无效14例,总有效率为68.18%。2组比较,差异有统计学意义(P < 0.05)。治疗7 d后,2组VAS评分较治疗前均有降低,且治疗组低于对照组(P < 0.05)。治疗5周后,2组HSS评分较治疗前均有升高,且治疗组高于对照组(P < 0.05)。2组患者治疗期间均未发生明显药物不良反应。结论:玻璃酸钠联合复方倍他米松关节腔内注射治疗膝骨关节炎疗效显著,可以有效提高患者膝关节功能,缓解疼痛程度,且安全性较高。

  【关键词】 骨关节炎,膝;玻璃酸钠;复方倍他米松;临床疗效

 

Clinical Observation on 44 Cases Treated with Sodium Hyaluronate Combined with Compound Betamethasone

DU Li-qun

 

  ABSTRACTObjective:To observe the clinical efficacy of sodium hyaluronate combined with compound betamethasone in the treatment of knee osteoarthritis.Methods:Eighty-eight patients with knee osteoarthritis were randomly divided into a treatment group and a control group,44 cases in each group.The control group was given intra-articular injection of sodium hyaluronate,and the treatment group was given intra-articular injection of compound betamethasone on the basis of the treatment for the control group.The clinical efficacy,visual analogue scaleVAS,Hospital for Special Surgery Knee ScoreHSSand adverse drug reactionsADRwere observed before and after treatment.Results:In the treatment group,14 cases were markedly effective,26 cases were effective,4 cases were ineffective,and the total effective rate was 90.91%,while in the control group,10 cases were markedly effective,20 cases were effective,14 cases were ineffective and the total effective rate was 68.18%.The difference between the two groups was statistically significantP < 0.05.After 7 days of treatment,the VAS of the two groups was lower than that before treatment,and that of the treatment group was lower than the control groupP < 0.05.After 5 weeks of treatment,the HSS of the two groups was higher than that before treatment,and that of the treatment group was higher than the control groupP < 0.05.No obvious adverse reactions were observed in the two groups during treatment.Conclusion:Intra-articular injection of sodium hyaluronate combined with compound betamethasone is effective in the treatment of knee osteoarthritis,which can effectively improve knee joint function and relieve pain,safe.

  Keywords osteoarthritis,knee;sodium hyaluronate;compound betame-thasone;clinical efficacy

[上一篇]白细胞介素类生物制剂治疗类风湿关节炎安全 [下一篇]中药封包对膝关节镜术后残留疼痛及白细胞介

友情链接:

百度 中国科学技术协会 中华中医药学会 中华医学会 中华医学会风湿病分会 中华中医药学会风湿病分会 中国中西医结合学会 中国中西医结合学会风湿病专业委员会 河南风湿网 河南风湿病医院
版权所有:Copyright 2002-2010 风湿病与关节炎 备案:豫ICP备11007478号-1